D-0864-2020 Class I Terminated

Recalled by Hikma Pharmaceuticals USA Inc. — Cherry Hill, NJ

Recall Details

Product Type
Drugs
Report Date
January 22, 2020
Initiation Date
December 17, 2019
Termination Date
June 9, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
101,710 25 vials/shelf-pack

Product Description

Ketorolac Tromethamine Injection, USP 30 mg/mL, packaged in 1 mL Single Dose Vials (NDC 0641-6042-01), 25 vials/shelf-pack (NDC 0641-6042-25), For IV or IM Use Only, Rx only, Manufactured by: WEST-WARD Eatontown, NJ 07724 USA.

Reason for Recall

Presence of Particulate Matter: particles identified as polydimethylsiloxane (PDMS)

Distribution Pattern

Nationwide within the United States

Code Information

Lot #: 038366, Exp. Date Mar 2020; 048365, 048367, Exp. Date Apr 2020; 078301, 078303, Exp. Date July 2020; 118358, Exp. Date Nov 2020; 029353, Exp. Date Feb 2021; 019413, Exp. Date Jan 2021